The Food and Drug Administration’s April draft guidance for diversity in clinical trials is a new area to incorporate, but there are other factors to consider when implementing or expanding research. Here’s a checklist to help organizations help think them over. It was developed by PYA in conjunction with Rhonda Paz, Managing Principal of Clinical Trial Administrators. Contact her at rhonda@ctadministrators.org.
1. Organizational Support |
---|
a. Is leadership looking for a new revenue opportunity? |
b. Is leadership looking for ways to enhance the organization’s reputation and/or differentiate it from competitors? |
c. Is the organization looking for ways to minimize outmigration and attract new patients? |
d. Does the organization desire to achieve or maintain specialized accreditations requiring clinical trial participation? |